Monday, May 25, 2026 | 11:06 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Wockhardt Ltd News

Stocks to buy: Wockhardt, TFCI, HBL Engg among analyst's top bets; check TP

Kunal Kamble, sr. technical research analyst at Bonanza, has recommended buying shares of Wockhardt, TFCI, and HBL Engineering today

Stocks to buy: Wockhardt, TFCI, HBL Engg among analyst's top bets; check TP
Updated On : 07 May 2026 | 6:30 AM IST

Nifty Pharma hits 52-wk high; Wockhardt up 15%, Laurus, Lupin at new peaks

The Nifty Pharma index was quoting higher for the fifth straight trading day, surging 3.8 per cent during the period, as against 0.37 per cent gain in Nifty 50.

Nifty Pharma hits 52-wk high; Wockhardt up 15%, Laurus, Lupin at new peaks
Updated On : 06 May 2026 | 1:15 PM IST

Wockhardt jumps 10% on posting Q4 profit turnaround; revenue up 30% YoY

In the March quarter (Q4FY26), Wockhardt posted net profit year-on-year (Y-o-Y) of ₹166 crore, as compared to a net loss of ₹25 crore a year ago

Wockhardt jumps 10% on posting Q4 profit turnaround; revenue up 30% YoY
Updated On : 05 May 2026 | 10:03 AM IST

Lupin, Biocon: Nifty Pharma gains 3% after US-India trade deal pact

According to Axis Securities, the reduction in reciprocal taxes is incrementally positive for Indian pharmaceutical companies, particularly those with significant exposure to the US market,

Lupin, Biocon: Nifty Pharma gains 3% after US-India trade deal pact
Updated On : 03 Feb 2026 | 9:49 AM IST

Wockhardt soars 19% on huge volumes; here's why the pharma stock rose today

The company said the United States Food and Drug Administration (USFDA) has formally accepted the New Drug Application (NDA) for its first-in-class antibiotic 'Zaynich'

Wockhardt soars 19% on huge volumes; here's why the pharma stock rose today
Updated On : 01 Dec 2025 | 1:44 PM IST